Your browser doesn't support javascript.
loading
Progression-free survival of up to 8 months of an advanced intrahepatic cholangiocarcinoma patient treated with apatinib: a case report.
Ma, Fu-Chao; Yu, Qian; Zeng, Zhi-Ming; He, Rong-Quan; Mo, Chao-Hua; Zhong, Jin-Cai; Ma, Jie; Feng, Zhen-Bo; Chen, Gang; Hu, Xiao-Hua.
Affiliation
  • Ma FC; Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning.
  • Yu Q; Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning.
  • Zeng ZM; Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning.
  • He RQ; Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning.
  • Mo CH; Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.
  • Zhong JC; Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning.
  • Ma J; Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning.
  • Feng ZB; Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.
  • Chen G; Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.
  • Hu XH; Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning.
Onco Targets Ther ; 10: 5237-5242, 2017.
Article in En | MEDLINE | ID: mdl-29138576

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies Language: En Journal: Onco Targets Ther Year: 2017 Document type: Article Country of publication: New Zealand

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies Language: En Journal: Onco Targets Ther Year: 2017 Document type: Article Country of publication: New Zealand